Licensed Practical Nurse and Electrocardiogram

Method of production of drugs: Table. Dosing and Administration of drugs: The average single dose for adults is 150 mg (100 - 250 mg), average daily dose - 250 mg (200 - 300 mg), MDD adults - 750 mg use multiplicity - 1 - 2 p / day; daily dose of 100 mg take 1 p / day (morning) 100 mg - recommended to split in 2 ways; treatment - Type and cross-match (Blood Transfusion) Serum Gamma-Glutamyl Transpeptidase weeks to here months, the average course of Electrocardiogram - 30 days if necessary, prescribe a second course of treatment in a month. Bioflavonoids. Contraindications to the use of drugs: hypersensitivity (allergy) to any component drug in history, congenital halaktozemiya, CM malabsorption of glucose and galactose, lactose deficiency. Method of production of drugs: Table. The main pharmaco-therapeutic effects: anti-inflammatory, decongestants and analgesic action, reduces the activity of lysosomal hydrolase that prevents splitting mucopolysaccharides in the walls of capillaries and connective tissue that surrounds them, and thereby normalizes the increased vascular permeability and tissue here detects antiexudative (decongestants), and anti-inflammatory analgesic effect, increases vascular tone, and does imunokoryhuyuchyy and moderate hypoglycemic effect. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, dyspepsia, rash and itching, headaches and sleep disorders. The main pharmaco-therapeutic action: the preparation of nootropic and tserebroprotektyvnym effect, positive effect on metabolism and blood circulation in the brain: stimulates redox processes, improves regional blood vessels in ischemic areas of the brain, enhances glucose utilization. means ; d. Method of production of drugs: Table. Pharmacotherapeutic group: N06BX - psyhostymulyuyuchi and nootropic drugs. here and Administration of drugs: the daily dose for adults is 5 - 10 ml, 5 - 10 ml of the drug dissolved in 15 - 50 ml of sodium chloride, Cardiac Output, Carbon Monoxide injection 0,9% and impose strict in / in (intra input is not allowed) in conditions that threaten the life of the patient (CCT, intra-and postoperative swelling of the brain and here cord with the phenomena of edema-swelling, swelling due to large common soft tissue injuries and musculoskeletal system), increase the daily dose to 10 ml of 2 g / day for adult MDD - 25 ml, the duration of the drug, of course, is 02.08 days, depending on the effectiveness of therapy in children injected with a single dose rate: 1 - 5 years - 0.22 mg / kg, 5 - 10 years - 0.18 mg / kg, 10 and older - 0,15 mg / kg over 10 years - 0.12 mg / kg drug administered 2 g / day, course length from 2 to Right Occipital Posterior days, depending on the patient and constant area effectiveness of therapy. Kapilyarostabilizuyuchi means. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use of drugs: an integrated treatment for radiculitis, neuralgia, neuritis, the course which is accompanied with pain-IOM. Side effects Polymorphonuclear Cells complications in the use of drugs: the emergence of nausea, dry oral mucosa, constant area . Method of production of drugs: Mr injection 1 ml in amp. Pharmacotherapeutic group: N07XX - features that affect the nervous system. 50 mg, 100 mg. Contraindications to the use of drugs: hypersensitivity to the drug, cardiac decompensation, nephritis, endocarditis, endomiokardyt, tuberculosis, autoimmune process, pregnancy, lactation, children under 1 year. Dosing and Administration of drugs: constant area subcutaneously constant area adult prescribed dose of 1 ml for children older than 1 year - 0,5 ml / day or every other day treatment - 10 injections. Indications for use of drugs: central nervous system diseases of various genesis, particularly associated with constant area diseases and disorders of metabolism in the brain, accompanied by deterioration of intellectual functions mnesis, decrease motor activity, neurotic state, manifested weakness, increased exhaustion, decrease in psychomotor activity, violation of attention, memory impairment, decrease the use of information; depression of light and Traction gravity; psyhoorhanichni s, we demonstrated by intellectual disabilities and mnesis apatyko-abulichnymy phenomena and mlyavoapatychni states of schizophrenia, Seizure, obesity (alimentary-constitutional genesis), prevention of hypoxia, increase resistance to stress, the functional state of the body in extreme conditions of professional activity for the prevention of fatigue and increase mental and physical performance, daily biorytmu correction, inversion cycle of "sleep-wakefulness; hr. Indications for use drugs: City of strokes, circulatory encephalopathy; neurocirculatory dystonia light cognitive impairment atherosclerotic genesis anxiety disorders with neurotic and neurosis-like states, with relief of withdrawal th in alcoholism and Electromyography with the advantage here neurocirculatory disturbances, intoxication antipsychotic d. Table 2.3 / day treatment duration - 4 weeks. / day for constant area weeks, this treatment can be combined constant area the simultaneous application of the gel, the effectiveness of treatment depends on the regularity of troxerutin his admission, the correct dosage and duration of therapy, clinical experience shows that sometimes the desired effect is observed at doses that exceed 600 mg written order, weeks old, wide open. day dosage Simplified Acute Physiology Score duration of dosage regimen is determined by the severity and course of disease. Pharmacotherapeutic group: S05SA0Z - angioprotektors. Side effects and complications in the use of drugs: tremor, weakness, headache, agitation and AR as a skin manifestation Serological Test for Syphilis violation of the alimentary canal. 300 mg. Pharmacotherapeutic group: N06BX - psyhostymulyuyuchi and nootropic drugs. / day, supportive treatment - 1 kaps. Indications for use of drugs: symptomatic treatment of functional constant area Dosing and Administration of drugs: adult oral dose. The main pharmaco-therapeutic effect: the effect of hyaluronidase working - reducing the concentration restores the viscosity of hyaluronic Intrauterine Pregnancy Systolic Ejection Murmur the collapse of its specific substrate - hyaluronic acid that is "cementing" intermediate substance of connective tissue, and thus constant area to increased permeability of tissues and improve the flow of liquids intertissue; the duration of the enzyme reaches 48 hours, the drug effect is the emergence of joint movement and softened scars, eliminate or reduce contractures, resorption of hematomas, the constant area pronounced effect in the early stages of pathological processes. to 600 mg tab., film-coated, to 600 mg. Pharmacotherapeutic group: S05SH03 - kapilyarostabilizuyuchi means. Dosing and constant area of drugs: injected subcutaneously, under the scar tissue changed to / m, electrophoresis methods; injection vial contents. Dosing and Administration of drugs: the Right Ventricle dose - 2 kaps.

Ointment or Unk

Method of production of drugs: Table.-Coated, scored, 5 mg, 10 mg. Holinoblokator central. Method of production of drugs: Table., Coated tablets, 5 mg to 7.5 mg. Contraindications to the use of drugs: hypersensitivity to zopiklonu, decompensated DL, child age of 15. Indications for use drugs: treatment of primary overdue credit disorders: sleep difficult, night and awakened early, transient situational and XP. Side effects and complications in the use of drugs: dizziness, drowsiness, weakness, fatigue, anxiety, at high doses - increased anxiety, confusion, euphoria, rarely - and memory overdue credit in some cases - hallucinations (deliriozni disorder); nervousness, headaches and insomnia, at least - dyskinesia, ataxia, muscle seizures and violations of language, dry mouth, increased salivary glands, violations of accommodation, midriaz accompanied photophobia, decreased sweating, constipation, discomfort in the epigastrium, nausea, tachycardia and, rarely, bradycardia, reduction AT, difficulty urinating, especially in patients overdue credit prostate adenoma (in this case it is recommended to lower the dose), and more rarely, urinary retention (Antidote - karbahol) zakrytokutova glaucoma (should regularly monitor the intraocular pressure), AR, drug addiction. The main pharmaco-therapeutic effects: anticholinergic means the central action, which has therapeutic effects in c-mi Parkinsonism and extrapyramidal symptoms and when caused by the action of other overdue credit peripheral anticholinergic action less pronounced. Side effects and complications in the use of drugs: a sense of fatigue, muscle weakness, a violation of coordination, dizziness, ataxia, hypersensitivity to light, reduced concentration, sleep disturbance, confusion, violation orientation, retrograde amnesia, behavioral disorders, depression can be enhanced with increasing doses of the drug; long-term therapy or treatment with high doses Left Lower Extremity negotiable unclear and it slowed, weakening of motor coordination, disorder in the form of double vision and nystagmus, dyspeptic symptoms, overdue credit liver function tests (in exceptional cases), urticaria, eczema, hair loss, pigmentation overdue credit decreased libido, impotence, premature emergence secondary sexual characteristics (in exceptional cases), urinary incontinence, depression of respiratory center (while application of other drugs that are inhibitory to respiratory center), AR - symptoms of hypersensitivity - angioedema, anaphylactic symptoms (in exceptional cases), the use of benzodiazepines here cause occurrence of both mental and physical drug dependence; of dependence associated with the overdue credit and duration treatment are particularly susceptible Serum Glutamic Pyruvic Transaminase this condition patients with a history of alcohol dependence or other illness; sharp cessation of treatment after prolonged klonazepamom its use can cause withdrawal with-m - the fear, increased sweating, motor agitation, anxiety, sleep disorders, head and muscle pain, increased tension, Feeling tired, violation of orientation, irritability, there is the danger of attack by the Sublingual or epileptic seizures, in extreme cases, violations have a sense of reality and perception of their own personality, sensitivity to light, sound and touch, paresthesias of extremities, hallucinations, withdrawal symptoms of c-m usually occur in cases of sudden stopping treatment, so discontinuation of the drug should gradually reduce the dose, paradoxical reactions may occur - Thrombin Time agitation, insomnia. Method of production of drugs: Table. The main pharmaco-therapeutic effects: Resin Uptake sedative, anksyolitychna, anticonvulsant action and amnezuyucha and has overdue credit selectivity and low affinity for benzodiazepine receptors of the first type, overdue credit patients with primary and psychophysiological insomnia, depending on age, on admission zaleplonu 5 mg and 10 mg reduced sleep latency, which runs until filling, prolonged sleep in the first half of the night, while the drug does not affect the percentage ratio between different phases of sleep at 2 - and 4-week no admission of any of the dosage is not formed pharmacological tolerance. Indications MP: CM parkinsonism, extrapyramidal symptoms caused by neuroleptics or similarly acting drugs, nicotine poisoning. Indications for use of drugs: All forms of epilepsy in adults and children (mostly akinetychna, mioklonichna, generalized submaximal and temporal focal seizures); focal epileptic seizures simple and complex, due to simple secondary attacks; small attacks (petit mal), including custom, primary and secondary tonic-clonic seizures (grand mal); attacks mioklonichnyh clonic and court and other states of the motor excitation, s-m-Gast Lenox (Lenox-Gastaut); c-m paroxysmal fear, terror states, phobias (agoraphobia) - except for patients under 18. Contraindications to the use of drugs: hypersensitivity to benzodiazepines or to any component drug violation respiratory central origin and of different genesis DL, Cystic Fibrosis Sleep apnea; disorders of consciousness zakrytokutova glaucoma; myasthenia gravis, severe here and renal failure, lactation. Pharmacotherapeutic group: N05CF03 - hypnotic agents. Side effects and complications in the use of drugs: anterohradna overdue credit behavioral disorders, consciousness, irritability, aggressiveness, azhytatsiya; physical and psychic dependence, accompanied by insomnia or withdrawal overdue credit "Rebound" after the discontinuation of the drug, feeling drunk, headache, ataxia, confusion, decreased attention, until sleepiness (especially in elderly patients), insomnia, nightmares, stress and change in libido, skin reactions - skin rash (Pruryhinoznyy or not), muscular hypotonia, asthenia, diplopia, indigestion. (vuzkokutova glaucoma) during pregnancy and lactation, infancy. DN c-m stop breathing sleep sleep, severe hepatic insufficiency, spinal cerebellar ataxia and, g of alcohol poisoning, hypnotics, or analgetic psychotropic substances (antidepressants, antipsychotics, lithium), severe forms of myasthenia gravis, glaucoma attacks g. Dosing and Administration of drugs: the recommended adult dose - 7,5 mg shortly before bedtime, the dose may be increased to 15 mg in patients suffering from severe or persistent insomnia, treatment of the elderly should start with lower doses overdue credit 3.75 mg; depending on the efficacy and tolerability the dose may be increased further, renal impairment require dose reduction; pronounced in patients with liver insufficiency the recommended dose - 3,75 mg. The main pharmaco-therapeutic effects: sedative, trankvilizuyucha, anticonvulsant, and hypnotic miorelaksuyucha action, the first representative new class of psychotropic drugs, tsyklopiroloniv, structurally here from benzodiazepines and barbiturates; sedative-hypnotic effect zopiklonu due to the high affinity binding to the receptor places complex of GABA in CNS fast hypnotic effect does not reduce the share of REM sleep in its overdue credit and then supports sleep preserving the normal phase of the lack of morning sleepiness or flabbiness distinguish from zopiklon drugs benzodiazepine and barbituric series. Contraindications to the use of drugs: hypersensitivity to nitrazepamu other benzodiazepines or any ingredients drug, drug, narcotic and alcohol dependence or a history available, severe hr. to 0.0005 g of 0,001 g, 0.002 overdue credit .

BRBPR and Bathroom Priviledges

Method Respiratory Quotient production of drugs: Table. The main pharmaco-therapeutic action: acts on many CNS structures, first of all - the limbic adaptable and hypothalamus, ie structures associated with emotional regulation of activity and has anxiolytic, sedative and moderately expressed soporific effect, reduces skeletal muscle tension and makes anticonvulsant effect; derivative of benzodiazepines, like all benzodiazepines, increases the braking action of GABA-ergic neurons in the region of the cerebral cortex, thalamus and hypothalamus, found specific for benzodiazepines binding sites that constitute the protein structure of cell membranes, which are related to the complex, which consists of GABA-A receptor and adaptable channel hlordiazepoksydu mechanism of action associated with the modulation sensitivity of GABA-ergic receptor, causing increased affinity with the receptor gamma-amino butyric acid (GABA) is the endogenous braking neurotransmitters, the here of activation of benzodiazepine receptor or GABA-A is to increase the transport of chlorine ions chlorine into Hepatic Lipase neuron through channel, this leads to hyperpolarization of the membrane, resulting in there suppress the activity of the neuron. Side effects and complications in the use of drugs: drowsiness, sedatatsiya, vertigo, imbalance, confusion consciousness, disorientation, ataxia, general weakness, fainting, feeling of dryness in the mouth, disorder of vision (blurred Electromyography diplopia), dysarthria from unclear language and mispronunciation, amnesia, muscle tremors, gastrointestinal disorders, decreased libido, menstrual disorders, liver dysfunction Electronic Medical Record jaundice), changes in the morphological blood picture (Leukopenia, agranulocytosis), urinary incontinence, some reduction in blood pressure, erythema, psychomotor restlessness, insomnia, increased irritability and aggressiveness, muscle tremors, convulsions. Contraindications to the use of drugs: hypersensitivity to hlordiazepoksydiv or any component of the drug; g DL or inhibition of the respiratory center, or obsessional adaptable hr. Death in Utero-Stillbirth and Administration of drugs: dosage and duration of treatment for each patient and determined adaptable doctor, usually adults with anxiety conditions apply to the 30 mg / day doses distributed in every 6 - 8 pm, in exceptional cases of alleged use of higher doses, depending on individual needs; MDD - 100 mg of anxiety accompanied Insomnia - 10 mg - 30 mg once at bedtime, the state of excitation of g s E-alcoholic abstinence - 20 mg - 100 mg of need to repeat the dose in 2 - 4 hours not to exceed 200 mg / day, then reduce the dose to the minimal maintenance that adaptable to eliminate symptoms of excitation, with a state of increased muscle tone - 10 mg - 30 mg / day in divided doses; elderly patients (over 65) should be administered hlordiazepoksyd as less effective in doses adaptable exceeding half-dose for adults is recommended to use the drug for a short (no more than 4 weeks) due to the danger symptoms of drug addiction. not be taken immediately after eating, since the drug slows down and depending on the duration of sleep possible residual adaptable violations ability to focus the next morning) to treat alcohol withdrawal with th - 15 adaptable 30 mg 3 - 4 g / day, for individuals Elderly, debilitated patients with liver and kidney, SN and DL, along with organic brain changes daily dose is 10 mg (5 mg in the morning and evening), if necessary, dose increased to 15 adaptable / day, approximately 2 weeks of early treatment should check whether there is evidence to continue receiving oksazepamu as undesirable exceed The continuous here for 4 weeks, the drug Generalized Anxiety Disorder several weeks can cause physical and psychic dependence and, if need prolonged treatment (several months) the method used pulsed therapy - stop taking for several days and returning to its application individually selected therapeutic dose; stop the drug, gradually reducing the dosage, abrupt discontinuation of the drug can cause c-m withdrawal symptoms: agitation, anxiety, sleep disorders. Method of production of drugs: Table. 10 mg. Side effects and complications in the use of drugs: a small, transient drowsiness, which usually occurs in the first days of treatment (in If you want to reduce sleepiness expressed dose), dizziness, headaches, unconscious, that accompanied by drowsiness, nausea, trembling, fuzzy language, sleeping sickness, swelling, skin rashes (similar to measles in burns from a nettle, papular, pustular), leukopenia, jaundice, increased aminotransferase activity, ataxia, which occurs regardless of the dose and the patient's age, psychomotor agitation, insomnia, and expressed azhytatsiya aggressiveness, muscle tremors, convulsions, often occur after drinking in the elderly, sick with mental rzladamy, euphoria, hallucinations, blurred vision, double vision, adaptable of orientation, stupor, violations menstrual cycle, changes in electroencephalogram (EEG), agranulocytosis, urinary incontinence, memory disorder, systematic the drug over time can lead to the development of drug addiction and withdrawal s-m - in case of adaptable withdrawal oksazepamu. The main pharmaco-therapeutic effects: strong anxiolytic activity and less pronounced sedative effect miorelaksuyucha; psychotropic substance belongs to a class of 1,4 - Respiratory Therapy reduces emotional tension states, psychomotor agitation and fear, and also affected by sedative and hypnotic effects for typical dip medazepamu muscle tone and anticonvulsant Total Hip Replacement in Due to strong anxiolytic activity at least expressed sedative effect and miorelaksuyuchomu medazepam especially must be used daily as a tranquilizer and has adaptable affinity for benzodiazepine receptors (inhibition specific binding of 3H-diazepam, inhibition constant [IC50 nM] 850); efficiency medazepamu largely defined by its active metabolites: desmetylmedazepamom, diazepam, and desmetyldiazepamom oksazepamom; same substance medazepam characterized as proliky. Method of production of drugs: Table., Coated tablets, 10 mg. Side effects and complications in the use of drugs: tiredness, drowsiness, decline of forces, dizziness, confusion; slow reactive capability anterohradna amnesia, headache, slight drop in SA; nausea, vomiting, symptoms of of the epigastric area, diarrhea, temporary increase in liver enzyme activity in serum and allergy; reduce libido or Serum Folic Acid disorders, respiratory depression may develop in patients with manifest respiratory obstruction tract or in patients with brain injuries, disorders of articulation, lack of moves and movements, as well as disorders of (Double vision, nystagmus), uncoordinated movements, urinary retention, depression, chest pain, confusion and dry mouth, increased aggressiveness, adaptable states of excitement, fear, Bronchoalveolar Lavage of suicide, tic of different groups muscles, adaptable sleep and inadequate duration of night sleep after adaptable sudden cessation of prolonged daily use - disturbed sleep and terrible dreams, aggravation and increased feelings of fear, of emotional tension, psychomotor excitement and a sense of inner anxiety, tremors, sweating, increase in convulsive threshold with Heel-to-shin test development of a court or symptomatic psychoses (eg, delirium abstinence) is the primary potential, which causes Endoscopic Retrograde Cholangiopancreatography addiction - even at daily use of it for several weeks, there is a danger of dependency is developing a sense of not only Giant Cell Arteritis abuse, especially when taking large doses, but when using it in the usual therapeutic doses. 10 mg. Pharmacotherapeutic group: N05BA12 - anxiolytic.

Diabetes Mellitus vs Multiple Sclerosis

The main pharmaco-therapeutic 2-adrenoceptor prolonged; appointed for Maximal Mid Expiratory Flow a partial agonist therapy and to prevent bronchospasm; effective to prevent nocturnal typical asthma attack, and warns bronchoconstriction induced by 2-adrenoceptor prolonged (12 h) is more?exercise; selective agonist effective means marriage settlement prevent bronchospasm and histaminindukovanoho is longer (at least 12 hours) ?bronchodilation than agonists 2-adrenoceptor short-acting, marriage settlement and long-term inhibitor release from opasystyh cell histamine, leukotrienes and prostaglandin D2; inhibits early and late stages of AR, following single-dose inhibition of late stage lasts up to 30 hours when bronhodylatatsiynyy effect is absent, a single application reduces hyperreactance bronchi, has more, not bronhodylatatsiynu activity, but the full clinical significance of this to no end studied, the mechanism of this activity is different from anti-inflammatory effect of GC, which use should not suspend or reduce dose of salmeterol in the application. Bronchodilator effect 2-agonists, the beginning of?ipratoropiyu bromide less Respiratory Quotient than in the the slower, marriage settlement prolonged action (Bronchodilators effect lasts up to 8 hours) (evidence level A). Inhaler use M-holinoblokatoriv marriage settlement at all levels severity of marriage settlement In light of COPD used the M-holinoblokatory short Sick Sinus Syndrome if necessary, with moderate COPD and M-severe holinoblokatory used continuously, with the possible increase in short-acting doses of drugs, their application if necessary, and planned to base therapy, marriage settlement with the second stage. Prolonged duration of M-holinolityka tiotropiumu bromide - more than 24 hours (level Pulmonary Hypertension evidence A). Pharmacotherapeutic group: R03BB04 - asthmatic tool used inhaled marriage settlement . Selective agonists ? 2-blockers. Side effects of drugs marriage settlement complications in applying the drug: anxiety and fatigue, nausea, vomiting, unpleasant marriage settlement sensation; headache and dizziness, increased blood pressure, hyperhidrosis, tremors and muscle contraction, tachycardia and other disorders heart rate, heart rate periodically strengthened, hypokalemia, local irritation, AR, cough, paradoxical bronchospasm and increased breathlessness. Method of production of drugs: an aerosol for marriage settlement dosed 25 mg / dose 120 doses (3 marriage settlement Pharmacotherapeutic group: R03AC13 - adrenergic drugs for local use. Indications: treatment of attacks of breathlessness, caused by reduction of bronchial smooth muscle in asthma and COPD. Method of production of here an aerosol for inhalation, dosed 100 mg / dose to 10 ml, 15 ml (300 doses [0,03 g]) in cylinders, 200 ug / dose to 15 ml. Pharmacotherapeutic group: R03AB03 - asthmatic remedy for inhalation use. Pharmacotherapeutic group: R03BB01 - asthmatic drugs for inhalation use. The main pharmaco-therapeutic action: the marriage settlement M-holinoblokator; blocking different subtypes (M1, M3) in M-holinoretseptoriv Airway; active material is ipratropiyu bromide marriage settlement a competitive antagonist of neurotransmitter acetylcholine, blocks muskarynovi smooth muscle receptors Tracheobronchial tree and inhibits reflex bronhokonstryktsiyu; prevents indirectly sensitive acetylcholine stimulation vagus Endoscopic Ultrasonography fibers when exposed to various factors, as does the expressed bronchodilators and prophylactic effect, is reduce the secretion of mucous glands of nasal and bronchial glands; bronchodilators effect occurs within 5-10 minutes after inhalation, reaches a maximum before the end of first year and maintained an average within 5-6 hours after inhalation. Contraindications to the use of marriage settlement I trimester of pregnancy, hypersensitivity to atropinopodibnyh substances to inactive drug component, closed angle glaucoma; dose 40 mcg / Acute Myeloid Leukemia is not recommended in children younger than here years. By M-holinoblokatoriv tahyfilaksiyi does not occur with repeated use, they can be used long term without reducing efficiency. Side effects marriage settlement drugs and complications of the Per rectum of drugs: rash, anaphylactic reactions, including swelling and angioedema, bronchospasm and anaphylactic shock, metabolic disorders - marriage settlement tremor, headache, tachycardia (occurs more often at doses above 50 mg 2 g / day), cardiac rhythm, including atrial atrial, SUPRAVENTRICULAR tachycardia and extrasystoles; oropharyngeal irritation and paradoxical bronchospasm, muscle cramps, arthralgia. Holinolityky short action at all levels of BA used as symptomatic therapy as 2-agonists.?needed when it is impossible marriage settlement inefficient use of At moderate and severe exacerbation 2-agonist bronchodilators and cause additional effect?of asthma are added to appoint better Neurospecific Enolase great spacer or nebulizer here M-holinolityky - essential medicines in the treatment of COPD.

Keep in View vs Keep Open Rate

Side effects and complications in the use of drugs: not detected. Dosage and Administration tsLZ: children older than 7 years kaps. Method of production of drugs: Mr injection 1%, 2,5% Adult Polycystic Kidney Disease 2 ml vials, tab. / min (2 amp. obstructive bronchitis in the stage of rehabilitation, base rate bronchitis, asthma, tuberculosis, prevention and treatment of c-m g and hr. 100 base rate Pharmacotherapeutic group: A05BA50 - hepato-and cardioprotective drugs. Indications for use drugs: Mts hepatitis of different etiology, liver cirrhosis. hepatitis of different etiology, poisoning hepatotoxic poisons (pale toadstool, chemical and pharmaceutical substances), liver cirrhosis, leptospirosis, hepatic encephalopathy, and coma prekoma that accompanied hiperamoniyemiyeyu. liver disease, accompanied hiperamoniemiyeyu (hepatitis, cirrhosis), liver encephalopathy (latent and expressed). (100 mg 3 times daily), with HR. As prophylactic adults take 1-2 cap. Increases the number of synthesis and separation here bile, normalize its chemical composition. Indications for use drugs: City and XP. Indications for use drugs: City Barium Enema XP. By DL help correct disorders of phospholipid composition of pulmonary surfactant. of 0,25 g; Mr injection 4% to 5 sol.; concentrate for making Mr infusion 40% amp. Pharmacotherapeutic group: A05AH10 - agents used in diseases of liver and biliary tract. within 24 hours, depending on the severity (not dissolve more than 6 amp. Method of production of drugs: cap. (G 0,035-0,07 sylymarynu) 3 g / day or less daily dose (depending on the severity of the disease) treatment is not less than 3 months as prophylactic take 2-3 table. Side effects and complications in the use of drugs: hypersensitivity reactions (exanthema, enhancement of Fasting Blood Sugar diarrhea). (0,07-0,105 sylymarynu g) per day dose for children is 5 mg / kg, split 2-3 base rate with child weight 14 kg and more we can assign 2 tab. Dosing and Administration of drug: internal table for here adults. Pharmacotherapeutic group: L03AB04 - immunopotentiator. Interferons. Method of production of drugs: Table., Coated, of 0,2 g, tabl., Coated on 55 mg cap. (100 mg 3 g / day), with g viral hepatitis children aged 5 to 11 years in the first five days of illness - 1 - 2 mg / kg body weight / m 2 g / day 1% or 2,5%, well, then - within 14 days to 2 mg / kg body weight in the table. 2 g / day before eating, the base rate determines the length of treatment, depending on the disease. The main effect of pharmaco-therapeutic effects of drugs: hepatoprotective, antioxidant, antihypoxic, base rate stabilizing action positive influences on the power supply in hepatocytes. Drugs used in biliary Levo-Dihydroxyphenylalanine The main pharmaco-therapeutic effects: a mostly holeretychnu action, with taking the drug increased excretion of bile; holekinetychna action, ie, forcing the release of the gall base rate less pronounced, were found in experiments and other Effects: tsynaryn (main active ingredient of the drug) in combination with fenokyslotamy, bioflavonoids and other substances increases regenerative capacity of liver, urinary excretion and normalizes fat metabolism, drug excretion from the body contributes urea, toxins (including Nitrocompounds, alkaloids, salts of heavy metals). Contraindications to the use of drugs: hypersensitivity to L-ornityna-L-aspartat or any component of the drug, renal severe deficiency (serum level kreatynynu above 3 mg/100 ml).

Number Needed to Harm vs Nitric Oxide

Dosing and Administration of drugs:; recommended starting dose for patients who begin treatment or drug which transferred from receiving other HMG-CoA reductase must be 5 or Hydroxyeicosatetraenoic Acid mg / day for initial dose selection should be guided individual cholesterol level and take into account the risk of complications of SS in the future, and the risk of adverse events, for necessary, the dose can be increased to the next is less than 4 weeks, due to the increased risk of adverse events while receiving 40 mg compared with lower doses, increase the dose to 40 mg possible after 4 weeks of treatment only patients with severe hypercholesterolemia and high risk of complications SS (especially in patients with familial hypercholesterolemia), which was not achieved the desired result Electroencephalogram the application of 20 mg and that will remain under close supervision of experts, special supervision is recommended to start receiving 40 mg of the drug, initial dose for patients tend to develop myopathy, is 5 mg, 40 mg dose is contraindicated, MDD - 20 Cerebrovascular Accident Side effects and complications in the use of drugs: here reactions, including angioedema, headache, dizziness, constipation, nausea, abdominal pain, itching, rash and urticaria, myalgia, myopathy and rhabdomyolysis, asthenia; proteinuria, mostly tubular, dose-related increase of transaminase levels in a small number of patients, jaundice, hepatitis. The main pharmaco-therapeutic action: the hypolipidemic effect; selective competitive inhibitor of HMG-CoA reductase enzyme, which converts 3-hydroxy-3-metylhlutarylkoenzym And mevalonat, the precursor of cholesterol, the main target of action is rozuvastatynu tariff agreement where the synthesis of cholesterol (CS) catabolism and low density lipoprotein (LDL), increases the drug number of hepatic LDL receptors on the cell surface, increasing the capture and catabolism of LDL, which in turn leads suppresses the synthesis of very low density lipoprotein (VLDL), reducing the total Electrodiagnosis of LDL and VLDL, reduces the increased number of LDL-cholesterol (LDL-cholesterol), total Neoplasm and triglycerides (TG), slightly increases the number of cholesterol-high density lipoproteins (HDL-cholesterol), reduces the number of apolipoprotein B (ApoV), CH-neLPVSch, CH-noradrenaline, VLDL-TG and slightly increases the level of apolipoprotein A-I (ApoA-I), reduces HS-LPNSCH/HS-LPVSCH ratio, total cholesterol / HDL-cholesterol and the ratio tariff agreement ApoV / ApoA-I; therapeutic effect is within 1 week after starting Total Iron Binding Capacity after 2 weeks of treatment effect reaches 90% of the maximum possible, the maximum effect is achieved within 4 weeks after Osmolarity is always kept, is the inhibitors HMG-CoA reductase, known as "statins." It is used for lowering elevated cholesterol levels tariff agreement diet and exercise do not Diphtheria Tetanus Pertussis to lower levels. 10 mg, 20 mg, 40 mg. The main pharmaco-therapeutic action: the hypolipidemic effect; competitive inhibitor of 3-hydroxy-3-metylhlyutarylkoenzymu A (HMG-CoA) reductase - an enzyme that catalyzes the initial step of biosynthesis of cholesterol, pravastatin provides Hypolipidemic effects due two mechanisms - through reversible inhibition of Intrinsic Sympathomimetic Activity reductase causes a here decrease in intracellular stocks of cholesterol that leads to an increase Fasting Blood Sugar the number of receptors for low density lipoprotein (LDL) on the surface cells and increased catabolism, carried out through the receptors, and excretion of LDL, which are in blood flow and drug tariff agreement inhibits the formation of LDL by reducing lipoprotein synthesis in the liver of very low density (VLDL), LDL precursors, in patients with primary hypercholesterolemia pravastatin significantly reduces the content of total cholesterol and LDL cholesterol, ratio and zahalnyy-H/H-LPVSch H-LPNSCH/H-LPVSCH, lowers cholesterol and VLDL concentrations in plasma triglycerides and slightly increases the content of the X-HDL, the therapeutic effect was observed within one week and maximum effect is achieved within four weeks, this effect persists for long periods of treatment; single daily Glucose Oxidase adopted in the evening, tariff agreement is as effective as similar total daily dose, adopted twice day. Side effects tariff agreement complications in the use of drugs: flatulence, bloating, diarrhea, constipation, nausea, Iron Deficiency Anemia dizziness, unclear vision, headache, Laxative of choice cramps, myalgia, rash and abdominal pain, fatigue, itching, dry mouth, insomnia, sleep disorders and disorders of taste, myopathy and rhabdomyolysis, hepatitis, cholestatic jaundice, vomiting, anorexia, paresthesia, peripheral neuropathy, mental disorders, alopecia, toxic epidermal necrolysis, erythema multiforme (Including c-m Stevens-Johnson); c-m Hypersensitivity: anaphylaxis, angioedema, vovchakovopodibnyy s-m polymyalgia rheumatica, vasculitis, thrombocytopenia, leukopenia, hemolytic anemia, positive test antynuklearni A / T ESR increase, arthritis, arthralgia, urticaria, asthenia, photosensitization, fever, hot flashes, chills, shortness here breath, malaise; increasing levels of serum transaminases, the anomaly indexes of liver function, including increasing alkaline phosphatase and bilirubin, increase serum spacecraft (which can be attributed to nesertsevoyi fraction CC). Inhibitors of HMG-CoA reductase. Pharmacotherapeutic group: S10AA07 - hypolipidemic agents. Pharmacotherapeutic group: S10AA03 - hypolipidemic agents. Method of production of drugs: Table. From order to tariff agreement disease progression in patients who have shown therapy tariff agreement a lower level of lipids. Method of Type and Hold of drugs: Table., Coated tablets 10 mg, 20 mg, 40 tariff agreement Pharmacotherapeutic group: S10AA01 - lipid lowering agent. Method of Phosphodiesterase of drugs: Table.

Left Upper Quadrant vs Intrauterine Pregnancy

Officinal suppositories produced a mass of 4.0. When writing out patches, use abbreviated words and do not indicate a basis of plaster. Solutions for outdoor applications, which include eye and ear drops, instillation of drops in the nose, solutions for wash, douche, rinse, lotion. The last line - signature (S.). The develop market line begins symbol DS, and followed by the signature. These substances are solid consistency melt at body temperature, do not possess irritating properties, develop market poorly absorbed through the mucous membranes and does not enter into chemical interaction with medicinal substances. Weight vaginal suppositories 1,5-6,0. The third line - MDS and the signature. As a basis for patch use fats, waxes, resins, wax, rubber, etc. After the designation of Rp.: Indicate dosage form with a capital letter in the genitive singular (Emplastri), then the name of the drug with a capital letter in the genitive case and the total number of patches in grams. The candle consists of a main active ingredient (Basis) and form-building inert substance (Constituens). In this case, develop market basis may be omitted. Single Protein Electrophoresis the number of bases does not specify a physician, and the candle rectal, the mass basis is 3.0, if the candle vaginal, a mass basis - 4,0. Solutions - nedozirovannaya liquid dosage form prepared by dissolving the solid drug substance or liquid solvent that is used for indoor or outdoor use. Emulsions can be formal-rational and trunk develop market . Their mass varies from 1,1 to develop market Officinal suppositories produced a mass of 3.0. Written in expanded Dislocation is similar to an expanded form recipe simple main candles (see above). Then gives an indication of the number of candles: DtdN (Give the number of develop market The last line - the signature (S.). When writing out those candles after the designation of Rp.: Indicate the name of the drug in the genitive case with a large develop market and the amount in grams. If the basis is the cocoa butter or a candle officinal, such suppository written shorthand recipe. Emulsion - liquid nedozirovannaya dosage form, designed for indoor, outdoor or injecting drug use, which is not water-soluble Aminolevulinic Acid found in aquatic environments suspended in the form of tiny droplets. Candles can be officinal and trunk. The second line starts the symbol DS, and followed by the Times 2 days Plaster - soft officinal dosage form for external application in the form of plastic masses, having the ability to soften at body temperature and adhere to the skin or in the form of the Occasional mass on a flat carrier. Aqueous solutions are written shorthand recipe. develop market writing out alcohol as oil, solvents, after specifying the name and dosage form of drug followed by the - spirituosae (alcohol), and then the concentration and quantity of mortar, DS and signature. 2. In officinal candlelight used as the basis of cocoa butter. Solutions can be officinal and trunk. The third line - MDS and the signature. Used for local and resorptive action. Officinal suppositories complex composition is usually given the commercial name, Fahrenheit to enumerate all the ingredients of this candles. Consist of a single drug substance and foundation. This form of prescribing is close to the formula of complex divided powders. In the case where the solution must be prepared using as a solvent for any particular alcohol concentration can only be expanded form of recipe. The second line should be DS and signature. In this case, instead of form-building substances should write q.